Phospholipid-mediated signaling systems as novel targets for treatment of heart disease

Author： Tappia Paramjit S.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.85, Iss.1, 2007-01, pp. : 25-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Micro- and Macrovascular Treatment Targets in Scleroderma Heart Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 536-544

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate-Mediated Signaling and Autism Spectrum Disorders: Emerging Treatment Targets

By  

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5186-5193

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic targets for the treatment of Fabry disease

By Hollak Carla EM   Vedder Anouk C   Linthorst Gabor E   Aerts Johannes MFG  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 821-833

Informa Healthcare

Access to resources Recommend Favorite

Novel targets for the treatment of autosomal dominant polycystic kidney disease

By Belibi Franck A   Edelstein Charles L  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 3, 2010-03 ,pp. : 315-328

Informa Healthcare

Access to resources Recommend Favorite

Caveolae and Caveolin-1: Novel Potential Targets for the Treatment of Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 13, Iss. 17, 2007-06 ,pp. : 1761-1769

Bentham Science Publishers

Access to resources Recommend Favorite